INO today
$1.46-$0.02 (-1.36%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourBullish
15 minExpanding
5 minAscending Triangle
Daily trend turns up above $1.18
Key levels
Resistance$2.17
Resistance$1.79
Support$1.45
Support$1.18
Latest news & SEC filings
AnalystPiper Sandler repeats bullish call on Inovio Pharmaceuticals, lifts target
AnalystHC Wainwright repeats Buy rating on Inovio Pharmaceuticals with $5 target
AnalystPiper Sandler keeps Overweight on Inovio Pharmaceuticals, cuts price target to $6
All INO news →About Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage biotechnology company that develops DNA-based medicines. Its approach pairs engineered DNA plasmids with its proprietary CELLECTRA electroporation devices to deliver treatments into cells. The lead candidate, INO-3107, is being developed for recurrent respiratory papillomatosis, while other programs target HPV-driven cancers and infectious diseases. The company is based in the United States and works with collaborators and government agencies on research and development.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
INOVIO PHARMACEUTICALS, INC. (INO)
What Is the Price Target for INO?
SEPT Low Target
$4.00
SEPT Mid Target
$5.00
SEPT High Target
$8.00
Analyst Consensus
$5.00
Is INO a Buy or Sell Right Now?
Thesis
- •Revenue growing -70.0% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for INO.
Start Free Trial →Is INO Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$3.79
17
Moat Score
NONE
0/9
Piotroski Score
-37.1
Altman Z-Score
What Is Smart Money Doing with INO?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Sumner Michael John | officer | Sale | 2,693 | $3K | May 20, 2026 |
| Shea Jacqueline Elizabeth | director officer | Sale | 12,306 | $15K | May 20, 2026 |
| Humeau Laurent | officer | Sale | 2,163 | $3K | May 20, 2026 |
| KIES PETER | officer | Sale | 4,688 | $6K | May 20, 2026 |
| Sumner Michael John | officer | Sale | 680 | $884.00 | May 15, 2026 |
| Shea Jacqueline Elizabeth | director officer | Sale | 7,717 | $10K | May 15, 2026 |
| Humeau Laurent | officer | Sale | 1,712 | $2K | May 15, 2026 |
| KIES PETER | officer | Sale | 2,571 | $3K | May 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →INO Growth Story
Revenue YoY
-70.0%
3yr Revenue CAGR
-81.5%
EPS Growth YoY
54.18%
FCF Growth YoY
15.0%
Revenue Trend
ACCELERATING
Dark Pool Trades for INO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for INO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:00:13 | $1.47 | 2,000 | $$3K | BUY |
| 18:00:03 | $1.46 | 10,000 | $$15K | SELL |
| 17:59:06 | $1.47 | 2,000 | $$3K | BUY |
| 17:59:06 | $1.47 | 2,000 | $$3K | BUY |
| 17:58:36 | $1.46 | 1,407 | $$2K | BUY |
5 dark pool trades shown · $$25K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for INO
PREVIEWSEPT Investing provides real-time options flow tracking for INO, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $1 | Nov 13 | 1 | $$40 | 1 | SWEEP |
| PUT | $1.5 | Nov 27 | 15 | $$60 | 4 | SWEEP |
| PUT | $1.5 | Nov 27 | 15 | $$60 | 4 | SWEEP |
| PUT | $1.5 | Nov 27 | 15 | $$150 | 10 | SWEEP |
| PUT | $1.5 | Nov 27 | 15 | $$15 | 1 | SWEEP |
5 options trades shown · 20% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for INOVIO PHARMACEUTICALS, INC. (INO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →INO — frequently asked questions
What is INO stock price today?
INOVIO PHARMACEUTICALS, INC. (INO) is at $1.46, down 1.36% (-$0.02) at the Nov 12, 2026 close.
Why is INO stock moving today?
Latest INO news — Nov 12, 2026: Piper Sandler repeats bullish call on Inovio Pharmaceuticals, lifts target · Nov 12, 2026: HC Wainwright repeats Buy rating on Inovio Pharmaceuticals with $5 target
What is the INO price target?
The average analyst price target for INO is $5.00, ranging from $4 to $8, based on 3 analysts. Latest: Jefferies maintains on Nov 7, 2026.
What do analysts rate INO?
Analyst ratings for INO: 3 Buy, 3 Hold, 0 Sell — consensus Hold.
Did INO beat earnings?
INO last reported on Aug 12, 2026: EPS -$0.07 vs -$0.22 expected — a beat of 67.7%.
Does INO pay a dividend?
INO does not currently pay a dividend.
What are INO support and resistance levels?
Support: $1.45, $1.18, $0.60. Resistance: $1.79, $2.17, $2.72.
What are insiders doing with INO?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on INO?
Nov 12, 2026: Piper Sandler repeats bullish call on Inovio Pharmaceuticals, lifts target · Nov 12, 2026: HC Wainwright repeats Buy rating on Inovio Pharmaceuticals with $5 target · Nov 11, 2026: Piper Sandler keeps Overweight on Inovio Pharmaceuticals, cuts price target to $6